| Bioactivity | Enecadin is a neuroprotective agent extracted from patent US 8623823 B2. | ||||||||||||
| Invitro | Enecadin is a neuroprotective agent which can be useful for the treatment of stroke or other cerebrovascular accident[1]. | ||||||||||||
| Name | Enecadin | ||||||||||||
| CAS | 259525-01-4 | ||||||||||||
| Formula | C21H28FN3O | ||||||||||||
| Molar Mass | 357.46 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Anil Gulati. Methods for treatment of stroke or cerebrovascular accidents using an ETB receptor agonist. US 8623823 B2. |